Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
CUSIP Nos. 54288CAA1 / U5423CAA6 Miami, FL, May 15, 2026 (GLOBE NEWSWIRE) -- MARA Holdings, Inc. (NASDAQ: MARA) (“MARA”) today announced the expiration and results of the previously announced...
-
NextNRG to Host First Quarter 2026 Financial Results Conference Call on May 18, 2026 at 9:00 a.m. ET
MIAMI, FL, May 15, 2026 (GLOBE NEWSWIRE) -- NextNRG, Inc. (NASDAQ: NXXT), a pioneer in AI-driven energy innovation transforming how energy is produced, managed, and delivered, today announced it...
-
Revenue Increased 29% Year-Over-Year to $21.1 Million While Gross Profit More Than TripledInterest Expense Declined 80% as Company Advances Microgrid Pipeline and Optimizes Fueling Operations MIAMI,...
-
Siebert Financial Corp. (NASDAQ:SIEB), a diversified provider of financial services, announces financial results for the first quarter ended Mar. 31, 2026.
-
NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- Blue Gold Limited (Nasdaq: BGL) (Nasdaq: BGLWW) (“Blue Gold” or the “Company”), a gold mining company with the infrastructure to deliver gold from...
-
Anoto Group AB (publ) ("Anoto") today publishes its annual report for 2025 and corrects for changes in the results as reported in the year-end report published on 27 February 2026. The annual report...
-
Anoto Group AB (publ) ("Anoto") publicerar idag sin årsredovisning för 2025 och korrigerar för förändringar i de resultat som rapporterades i bokslutskommunikén som publicerades den 27 februari 2026....
-
GAAP net loss of $10.8 million reflects approximately $5.2 million of share-based compensation and $3.4 million of one-time business-combination expenses; adjusted EBITDA loss was $3.2 million ARR...
-
ROCHESTER, NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- Syntec Optics Holdings, Inc. (Nasdaq: OPTX) (“Syntec” or the “Company”), a leading provider of advanced optics and photonics solutions across...
-
- Stenoparib clinical development continues in relapsed small cell lung cancer and, under FDA Fast Track designation, in advanced ovarian cancer- Allarity has received a Notice of Allowance for new...